Skip to main content

Genetic Diversity Analysis

Nutritional quality evaluation and genetic diversity analysis of walnut nuts


Walnut (Juglans regia L.) trees have been seed-propagated for over a thousand years in Tibet, thriving under variable climatic conditions at altitudes exceeding 3,000 m. This study conducted a comprehensive evaluation of the nutritional quality of 175 walnuts, identifying the highest-performing accessions. Additionally, 20 simple sequence repeat (SSR) loci were employed to assess the extent of genetic diversity and the genetic relationships among the walnuts. The walnut JC174, JC170, and JC126 were ranked among the top three based on a comprehensive evaluation using principal component analysis.

A total of 319 alleles were identified, and seven highly polymorphic loci, including SSR6, were selected for further study. The genetic diversity analysis indicated that the majority of genetic variation in Jiacha walnuts was observed among individuals, leading to the division of the population into two distinct groups. This study provides valuable theoretical insights and practical foundations for the advancement of the walnut industry in the Tibetan region.

The coefficient of variation among walnut monocultures in Jiacha County was found to be significant. Based on the comprehensive evaluation of the nutritional quality of Jiacha walnuts, the top three walnut trees were identified as JC174, JC170, and JC126, respectively. Jiacha walnuts can be broadly categorized into three types: nutritious fruits, fresh fruits, and balanced fruits. Furthermore, seven highly polymorphic loci were identified, and Jiacha walnuts were divided into two distinct taxa. This analysis clarified that the genetic variation in Jiacha walnuts primarily exists among individuals, with the YJN group exhibiting the highest degree of genetic differentiation. These findings provide the genetic foundation for the selection of breeding materials in future breeding programs.

Comments

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...